Skip to content

Efficacy of Er:YAG Laser in Decontamination of Dental Implants: An In-Vitro Study

Efficacy of Er:YAG Laser in Decontamination of Dental Implants: An In-Vitro Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03100435
Enrollment
8
Registered
2017-04-04
Start date
2017-04-20
Completion date
2018-10-18
Last updated
2023-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-Implantitis

Brief summary

The American Association of Oral and Maxillofacial Surgeons estimated that 69% of adults ages 35 to 44 have lost at least one permanent tooth. Dental implants have revolutionized dentistry by providing tooth-like replacement for missing teeth and a solution that is predictable with long-term success.. After the implant is placed, natural bacteria from the mouth can develop around implants just like around natural teeth. Studies have shown that bacterial contamination can cause peri-implantitis- gum disease or inflammation around the implant, eventually leading to bone loss. Removing bacteria from dental implant surfaces can prevent peri-implantitis, and surface debridement constitutes the basis of treatment of peri-implant disease. Typically, mechanical hand instrumentation using curettes to remove biofilm and calculus is the main basis for periodontal therapy. However, total debridement is difficult, and the hand tools may damage the surface of the implant and making it more plaque retentive. Studies have shown that mechanical non-surgical therapy alone is not sufficient to treat peri-implantitis. There is evidence that a dental laser may be an effective method to remove bacteria from implant surfaces, with less damage to the surface. One type of dental laser, Er:YAG, appears optimal for implant decontamination as the Er:YAG laser energy is primarily absorbed by water, resulting in vaporization of bacteria and minimal surface alterations on the implant surface.The aim of this study is to evaluate the efficiency of biofilm decontamination of Er:YAG laser compared to carbon fiber curette.

Detailed description

The aim of this study is to compare the amount of residual biofilm on titanium discs after decontamination with Er:YAG laser and carbon fiber curette. In the first phase of the study, custom mouth guards that holds multiple titanium discs will be fabricated. Experimental subjects will be instructed to wear this mouth guard for 72 hours, during which time a natural bacterial biofilm will form on the disc surfaces. The second phase of the study will be performed ex vivo after collecting the discs from the subjects. Discs retrieved from each mouth guard will be randomized over the 4 treatment groups, so that each subject will contribute two discs to each treatment group: 1) Er:YAG laser, 2) carbon fiber curette, 3) combination of carbon fiber curette and Er:YAG laser, and 4) no treatment (control). The biofilm will be stained and the residual biofilm will be visualized under fluorescence microscopy. Statistical methods will be used to determine the significance of each treatment modality. The primary outcome of the study is the percent area of the titanium disc covered by biofilm.

Interventions

DEVICEEr:YAG Laser

Titanium disks will be decontaminated ex-vivo with the Er:YAG laser.

OTHERCarbon Fiber Curette

Titanium disks will be decontaminated ex-vivo with carbon fiber curettes

Sponsors

Tufts University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

All participants will wear a mouth guard holding 8 titanium discs for 3 days, during which time a natural bacterial biofilm will form on the disc surfaces. After 3 days, the discs will be removed from the mouthguard, and treated ex vivo with different decontamination methods.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Presence of enough teeth to support the mouth guard. * Subjects diagnosed with clinical health, gingivitis, or slight chronic periodontitis defined as periodontal inflammation with slight (1-2mm) attachment loss.

Exclusion criteria

* Subjects with insufficient dental support for the mouth guard * Subjects diagnosed with moderate or severe chronic periodontitis. * Subjects with known allergy to acrylic or titanium. * Subjects who smoke cigarettes, cigars, snuff tobacco, or any other form of smoking. * Subjects with a history of antibiotic treatment within the last six months. * Subjects with contraindications to wearing a mouth guard, such as chronic obstructive pulmonary disease or severe sleep apnea. * Subjects with uncontrolled or debilitating medical conditions, including but not limited to subjects with uncontrolled diabetes, hematologic disorders, cancers, immunosuppression, severe cardiovascular disease, or uncontrolled thyroid disease * Subjects that are currently pregnant according to self-report

Design outcomes

Primary

MeasureTime frameDescription
Percent Bacteria Biofilm3 daysPercent area of the titanium disc covered by bacteria biofilm

Countries

United States

Participant flow

Recruitment details

From May 2017 to August 2018, 8 enrollments were made in the Department of Periodontology at Tufts University School of Dental Medicine

Pre-assignment details

Each subject participates in each arm, as 2 titanium discs from each subject are distributed among all 4 arms.

Participants by arm

ArmCount
All Study Participants
Titanium disks are decontaminated ex-vivo with the Er:YAG laser, with carbon fiber curettes, with titanium brush, or are not decontaminated .
8
Total8

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Age, Continuous31.6 years
STANDARD_DEVIATION 1.5
Race/Ethnicity, Customized
Asian
4 Participants
Race/Ethnicity, Customized
Hispanic
2 Participants
Race/Ethnicity, Customized
Indian
1 Participants
Race/Ethnicity, Customized
White
1 Participants
Region of Enrollment
United States
8 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 80 / 80 / 8
other
Total, other adverse events
2 / 82 / 82 / 82 / 8
serious
Total, serious adverse events
0 / 80 / 80 / 80 / 8

Outcome results

Primary

Percent Bacteria Biofilm

Percent area of the titanium disc covered by bacteria biofilm

Time frame: 3 days

Population: From 64 collected titanium disks, 5 were removed from analysis. 4 disks were dislodged from 2 enrolled participants and 1 disk was excluded due to improper magnification of the SYTO 9 imaging.

ArmMeasureValue (MEAN)Dispersion
LaserPercent Bacteria Biofilm32.78 percentage of disc coveredStandard Deviation 24
CurettePercent Bacteria Biofilm20.14 percentage of disc coveredStandard Deviation 19.15
BrushPercent Bacteria Biofilm11.8 percentage of disc coveredStandard Deviation 10.29
ControlPercent Bacteria Biofilm74.03 percentage of disc coveredStandard Deviation 21.61

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026